Medtronic backs legislators' bipartisan device tax repeal push; Tenex wins 510(k) for tissue removal device;

 @FierceMedDev: Merck IUD lot hit with Hong Kong recall. Report | Follow @FierceMedDev

 @MarkHFierce: A multi-gene sequencing cancer Dx test is hitting the U.K. health system, thanks to the NHS. More | Follow @MarkHFierce

 @DamianFierce: Researchers at the Cleveland Clinic are developing a breath-based diagnostic to detect heart failure. Story | Follow @DamianFierce

> Medtronic ($MDT) may be among the biggest device companies yet to speak out on the device tax repeal effort. The company issued a statement applauding efforts of the Minnesota legislative delegation to introduce bipartisan legislation to undo the tax. Statement

> A repeal of the 2.3% device tax would benefit companies including Johnson & Johnson ($JNJ), St. Jude Medical ($STJ), Boston Scientific ($BSX), CareFusion and Covidien ($COV), Fitch Ratings concludes. Release

> Biotronik won a CE mark for its next-generation DF4 ICD/CRT-D implants designed for safe MRI use. Release

> Tenex Health won 510(k) clearance for a new tissue removal system device designed for multiple types of surgery. Release

> Securities fraud class action cases against life sciences companies are on the rise. Story

> MedRobotics raised a $10 million debt round to fuel commercialization of its Flex robotic surgery device. Story

Biotech News

 @FierceBiotech: From FierceBiotechResearch.com: Researchers find possible cause of neuron dysfunction in Alzheimer's. Article | Follow @FierceBiotech

 @JohnCFierce: Another one bites the dust: Phytopharm slashes staff, scouts buyers after Parkinson's drug failure. Story | Follow @JohnCFierce

 @RyanMFierce: The top 10 moneymakers in Pharma, ordered by revenue and described in context: More | Follow @RyanMFierce

> PRACS' CRO implosion leaves a Who's Who of biopharma creditors in its wake. Story

> Headed into PhIII, Lundbeck scores $825M Alzheimer's drug pact with Otsuka. Report

> Ziopharm sharpens budget ax after cancer drug palifosfamide flops in PhIII. News

Pharma News

 @FiercePharma: Pfizer tuberculosis drug hits FDA shortage list, with other TB remedies already scarce. Story | Follow @FiercePharma

 @EricPFierce: Momenta's Kaundinya doesn't mind some regulatory chaos in biosimilars. It allows industry to help shape pathway. Special Report | Follow @EricPFierce

> Eli Lilly CEO's pay package slides 11% to $14.6M. More

> Despite sales slide, Bristol-Myers CEO nabs 15% raise to $17.2M. Story

Pharma Manufacturing News

> FDA fast-tracks plant for injectable on shortage list. More

> India state ups effort to root out counterfeits. Story

> Form 483 lays out latest issues dragging down Hospira. Report

> Sanofi, Transgene split cost of specialized manufacturing. Article

> Actavis puts $40M into Florida plant. More

Biotech Research News

 @EmilyMFierce: Could a canker sore treatment be the next weight-loss drug? More | Follow @EmilyMFierce

> UMD scientists test new bird flu vaccine in animals. Report

> Astellas strikes deals to hunt for dengue fever therapies. More

> New database could be a boon for genomics research. Story

> Tiny wireless sensor moves brain research forward. Item

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.